BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 7604782)

  • 1. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
    Goldberg RB; Roth D
    Am J Cardiol; 1995 Jul; 76(2):107A-109A. PubMed ID: 7604782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
    Holdaas H; Hartmann A; Stenstrøm J; Dahl KJ; Borge M; Pfister P
    Am J Cardiol; 1995 Jul; 76(2):102A-106A. PubMed ID: 7604781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.
    Jacotot B; Benghozi R; Pfister P; Holmes D
    Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.
    Leitersdorf E; Muratti EN; Eliav O; Peters TK
    Am J Cardiol; 1995 Jul; 76(2):84A-88A. PubMed ID: 7604807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
    Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine.
    Goldberg R; Roth D
    Transplantation; 1996 Dec; 62(11):1559-64. PubMed ID: 8970607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial.
    Zavoral JH; Haggerty BJ; Winick AG; Bergmann SD
    Am J Cardiol; 1995 Jul; 76(2):37A-40A. PubMed ID: 7604795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia.
    Eliav O; Schurr D; Pfister P; Friedlander Y; Leitersdorf E
    Am J Cardiol; 1995 Jul; 76(2):76A-79A. PubMed ID: 7604804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group.
    Jacotot B; Banga JD; Waite R; Peters TK
    Am J Cardiol; 1995 Jul; 76(2):41A-46A. PubMed ID: 7604796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database.
    Peters TK; Muratti EN; Mehra M
    Am J Med; 1994 Jun; 96(6A):79S-83S. PubMed ID: 8017471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
    Ghods AJ; Milanian I; Arghani H; Ghadiri G
    Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage.
    Smit JW; Jansen GH; de Bruin TW; Erkelens DW
    Am J Cardiol; 1995 Jul; 76(2):126A-128A. PubMed ID: 7604787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
    Peters TK
    Am J Cardiol; 1995 Jul; 76(2):71A-75A. PubMed ID: 7604803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of hypercholesterolemia of renal transplant allograft recipients with fluvastatin and gemfibrozil.
    Vergoulas G; Miserlis G; Solonaki F; Imvrios G; Gakis D; Papanikolaou V; Papagiannis A; Visvardis G; Takoudas D; Antoniadis A
    Transpl Int; 2000; 13 Suppl 1():S64-7. PubMed ID: 11111964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
    Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK; Mak TW; Chan TH; Wang A; Lam CW; Lai KN
    Transplantation; 1995 Oct; 60(7):652-6. PubMed ID: 7570971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.
    Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T
    Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin.
    Smit JW; Wijnne HJ; Schobben F; Sitsen A; de Bruin TW; Erkelens DW
    Am J Cardiol; 1995 Jul; 76(2):89A-96A. PubMed ID: 7604808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluvastatin on lipid profile and apolipoproteins in Chinese patients with hypercholesterolemia.
    Tomlinson B; Mak TW; Tsui JY; Woo J; Shek CC; Critchley JA; Masarei JR
    Am J Cardiol; 1995 Jul; 76(2):136A-139A. PubMed ID: 7604789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.